Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA) announced an exclusive collaboration with Sandoz, the generics business of Novartis (NYSE: NVS), to develop ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE